+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Negative Pressure Wound Therapy (NPWT) - Global Market Trajectory & Analytics

  • PDF Icon

    Report

  • 443 Pages
  • March 2022
  • Region: Global
  • Global Industry Analysts, Inc
  • ID: 5303656

Global Negative Pressure Wound Therapy (NPWT) Market to Reach US$3.1 Billion by the Year 2026


Negative pressure wound therapy represents an exciting advancement in wound care space that holds a number of clinical applications. The therapy is an effective option for treatment of non-healing complex wounds, categorized into chronic and acute wounds. Also referred to as vacuum-assisted closure, the technology is primarily used for management of wounds characterized by high exudate levels. The therapy is finding increasing use for management of diverse types of chronic and acute wounds, such as diabetic foot ulcers, skin grafts or closed surgical incisions. The global market for NPWT devices is on a growth path, on account of the rising incidence of chronic diseases including diabetes, and increasing surgical procedures. Diabetes entails the risk of causing diabetic foot ulcers and its treatment might require the use of NPWT devices. Similarly, immobility for long periods can lead to pressure ulcers, the treatment of which might need the use of NPWT devices. Also, the expanding aging population suffering from various diseases which restrict their mobility bodes well for the demand for NPWT devices. Government efforts for the prevention of SSIs, and the increasing caesarean section procedures among older mothers are also fostering the use of NPWT devices (post-operative). The availability of new options such as single-use negative pressure wound therapy is advancing the use potential. The market is also expected to gain from the development and launch of sophisticated NPWT devices that are user friendly. While NPWT pumps are advancing, even wound dressings are evolving such as antimicrobial contact layers and incisional management dressings. The introduction of affordable disposable NPWT by leading companies and rising awareness of this among people is likely to drive market gains.

Amid the COVID-19 crisis, the global market for Negative Pressure Wound Therapy (NPWT) estimated at US$2.4 Billion in the year 2022, is projected to reach a revised size of US$3.1 Billion by 2026, growing at a CAGR of 6.1% over the analysis period. Conventional, one of the segments analyzed in the report, is projected to grow at a 5.7% CAGR to reach US$2.3 Billion by the end of the analysis period. After a thorough analysis of the business implications of the pandemic and its induced economic crisis, growth in the Single-Use segment is readjusted to a revised 7.1% CAGR for the next 7-year period. This segment currently accounts for a 28.4% share of the global Negative Pressure Wound Therapy (NPWT) market. While conventional devices lead the market, these systems are for use in hospitals and are not appropriate for homecare settings, as they entail the usage of bulky canisters. Such devices can be purchased and also rented, which is anticipated to augment NPWT usage in developing countries. Single use NPWT is likely to register strong growth owing to their suitability for use in homecare settings. The growing trend of patient transition to home care settings in Europe and North America is therefore expected to drive their demand. Further, the advantages offered by single use NPWT such as battery based pump, appropriateness for treating moderate to low exuding wounds, lower cost, and their growing availability in the market are also fueling their adoption.



The U.S. Market is Estimated at $1.2 Billion in 2022, While China is Forecast to Reach $189.7 Million by 2026


The Negative Pressure Wound Therapy (NPWT) market in the U.S. is estimated at US$1.2 Billion in the year 2022. The country currently accounts for a 51.6% share in the global market. China, the world's second largest economy, is forecast to reach an estimated market size of US$189.7 Million in the year 2026 trailing a CAGR of 9.6% through the analysis period. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 4.3% and 6.3% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 5.6% CAGR while Rest of European market (as defined in the study) will reach US$124 Million by the close of the analysis period. North America is a key NPWT devices market, supported by the rising number of acute wound cases and the significant cost of treatment in the US, and easy device availability. Further, the expanding pool of burn patients and patients having pressure ulcers and diabetic foot ulcers on account of rising incidence of diabetes and obesity, are also fueling growth of the market. Increase in geriatric population who generally are vulnerable to various health conditions such as diabetes is also a providing a boost to the market. The NPWT devices market in APAC is anticipated to record strong growth, attributed to the rising incidence of chronic diseases, and the increasing number of people suffering from acute wounds.

Select Competitors (Total 54 Featured) -

  • 3M Company
  • Alleva Medical Ltd.
  • ATMOS MedizinTechnik GmbH & Co. KG
  • B. Braun Melsungen AG
  • Cardinal Health, Inc.
  • Carilex Medical GmbH
  • ConvaTec Inc.
  • Cork Medical, LLC
  • DeRoyal Industries, Inc.
  • Devon Medical Products
  • Genadyne Biotechnologies, Inc.
  • Lohmann & Rauscher GmbH & Co. KG
  • Medela AG
  • Mölnlycke Health Care AB
  • Paul Hartmann AG
  • Smith & Nephew PLC
  • Talley Group Limited
  • Triage Meditech Pvt. Ltd.

What's New for 2022?

  • Global competitiveness and key competitor percentage market shares
  • Market presence across multiple geographies - Strong/Active/Niche/Trivial
  • Online interactive peer-to-peer collaborative bespoke updates
  • Access to the publisher's digital archives and Research Platform
  • Complimentary updates for one year
Frequently Asked Questions about the Global Market for Negative Pressure Wound Therapy (NPWT)

What is the estimated value of the Global Market for Negative Pressure Wound Therapy (NPWT)?

The Global Market for Negative Pressure Wound Therapy (NPWT) was estimated to be valued at $2.4 Billion in 2022.

What is the growth rate of the Global Market for Negative Pressure Wound Therapy (NPWT)?

The growth rate of the Global Market for Negative Pressure Wound Therapy (NPWT) is 6.6%, with an estimated value of $3.1 Billion by 2026.

What is the forecasted size of the Global Market for Negative Pressure Wound Therapy (NPWT)?

The Global Market for Negative Pressure Wound Therapy (NPWT) is estimated to be worth $3.1 Billion by 2026.

Who are the key companies in the Global Market for Negative Pressure Wound Therapy (NPWT)?

Key companies in the Global Market for Negative Pressure Wound Therapy (NPWT) include Acelity, Cardinal Health, ConvaTec Group PLC, DeRoyal, Genadyne, KCI Licensing y, Lohmann & Rauscher GmbH & Co., Medela AG and Paul Hartmann AG.

Table of Contents

I. METHODOLOGY


II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

  • Impact of Covid-19 and a Looming Global Recession
  • COVID-19-Led Delay in Wound Care: The Dire Picture & Efforts to Improve Outcomes
  • Pandemic Shifts Focus to Home-Based Wound Care
  • Competition
  • EXHIBIT 1: Negative Pressure Wound Therapy (NPWT) - Global Key Competitors Percentage Market Share in 2022 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for 42 Players Worldwide in 2022 (E)
  • Wound & Wound Management: A Prelude
  • What is Negative Pressure Wound Therapy (NPWT)?
  • Negative Pressure Wound Therapy: Indications and Contraindications
  • Factors Driving Progression of Negative Pressure Wound Therapy
  • Single Use NPWT Experience Strong Growth Bolstered by Inherent Attributes and Increased Shifting of Wound care to Home Care Settings
  • Recent Market Activity
  • World Brands

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

  • Growing Emphasis on Preventive Wound Healing Bodes Well for NPWT Market
  • EXEXHIBIT 2: Leading Nosocomial Infections in the US: Percentage Breakdown of Healthcare Cost from Leading Five Infections
  • Rise in Caesarean Section Procedures Spurs Post-Operative Use of NPWT Devices
  • EXHIBIT 3: Number of Cesarean Section Procedures in the US (per 1,000 live births): 2008-2019
  • Technological Advancements and New Product Launches Crucial to Sustain Future Growth
  • Advancements in Foams and Dressings Extend NPWT Application to Outpatient Settings
  • Hybrid Negative Pressure Wound Therapy (hNPWT) Widens Growth Prospects
  • NPWTi-d Takes Negative Pressure Wound Therapy to Next Level with Cost Benefits
  • Rising Incidence of Chronic Wounds and Increasing HealthCare Burden Catalyze Growth Prospects
  • Chronic Wounds: Select Statistics
  • EXHIBIT 4: Global Prevalence of Wounds (in Millions)
  • EXHIBIT 5: Healing Time by Type of Wound (in Days)
  • How NPWT Aids in Healing of Acute Wounds
  • Rise in Prevalence of Pressure Ulcers to Drive Growth
  • EXHIBIT 6: Pressure Ulcer Occurrence Rate Based on the Length of Surgery
  • Global Epidemics of Diabetes and Increasing Incidence of DFUs to Propel Market Growth
  • EXHIBIT 7: World Diabetes and Population Statistics (2019, 2030 & 2045)
  • EXHIBIT 8: World Diabetes Prevalence (2000 - 2040P)
  • EXHIBIT 9: Global Diabetes Mellitus Population Breakdown by Geographic Region: 2019, 2030 and 2045
  • Aging Population: A Strong Growth Driver
  • EXHIBIT 10: Global Population Statistics for the 65+ Age Group in Million by Geographic Region for the Years 2019, 2025, 2035 and 2050

4. GLOBAL MARKET PERSPECTIVE


III. MARKET ANALYSIS

UNITED STATES

  • Negative Pressure Wound Therapy (NPWT) Market Presence - Strong/Active/Niche/ Trivial - Key Competitors in the United States for 2022 (E)
  • Market Analytics

CANADA


JAPAN


CHINA

EUROPE

  • Negative Pressure Wound Therapy (NPWT) Market Presence - Strong/Active/Niche/ Trivial - Key Competitors in Europe for 2022 (E)
  • Market Analytics

FRANCE


GERMANY


ITALY


UNITED KINGDOM


SPAIN


RUSSIA


REST OF EUROPE


ASIA-PACIFIC


AUSTRALIA


INDIA


SOUTH KOREA


REST OF ASIA-PACIFIC


LATIN AMERICA


BRAZIL


MEXICO


REST OF LATIN AMERICA


MIDDLE EAST


AFRICA

IV. COMPETITION

  • Total Companies Profiled: 54

Companies Mentioned

A selection of companies mentioned in this report includes:

  • 3M Company
  • Alleva Medical Ltd.
  • ATMOS MedizinTechnik GmbH & Co. KG
  • B. Braun Melsungen AG
  • Cardinal Health, Inc.
  • Carilex Medical GmbH
  • ConvaTec Inc.
  • Cork Medical, LLC
  • DeRoyal Industries, Inc.
  • Devon Medical Products
  • Genadyne Biotechnologies, Inc.
  • Lohmann & Rauscher GmbH & Co. KG
  • Medela AG
  • Mölnlycke Health Care AB
  • Paul Hartmann AG
  • Smith & Nephew PLC
  • Talley Group Limited
  • Triage Meditech Pvt. Ltd.